Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2351-2360

  Ma, Yu Fan ^a   Wang, Zhao ^a,b   Zhao, Wen ^a   Lu, Ting Li ^a   Wang, Ru Tao ^a,b   Mei, Qi Bing ^a   Chen, Tao ^a,c  

^a NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^b Shaanxi Liposome Research Center   (China)

^c Xi'an Libang Pharmaceutical Co Ltd   (China)

Author keywords

Bacteria; Fusion; Lipid composition; Liposomes; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM ION; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; GLYCEROPHOSPHOLIPID; LIPOSOME; PHOSPHOLIPID; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; IN VITRO STUDY; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; RIGIDITY;

BACTERIA; FUSION; LIPID COMPOSITION; LIPOSOMES; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; CHOLESTEROL; LIPOSOMES; MEMBRANE FUSION; NANOPARTICLES; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLGLYCEROLS; PSEUDOMONAS AERUGINOSA; TOBRAMYCIN;

BACTERIA (MICROORGANISMS); GLYCINE MAX; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84879891954     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S42617     Document Type: Article

References (40)

1. Beaulac C, Clement-Major S, Hawari J, Lagace J. In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition. J Microencapsul. 1997;14(3):335-348.
2. Omri A, Suntres ZE, Shek PN. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol. 2002;64(9):1407-1413.
3. Beaulac C, Sachetelli S, Lagace J. In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria. J Antimicrob Chemother. 1998;41(1):35-41.
4. Nicolosi D, Scalia M, Nicolosi VM, Pignatello R. Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria. Int J Antimicrob Agents. 2010;35(6): 553-558.
5. Drulis-Kawa Z, Dorotkiewicz-Jach A. Liposomes as delivery systems for antibiotics. Int J Pharm. 2010;387(1-2):187-198.
6. Drulis-Kawa Z, Gubernator J, Dorotkiewicz-Jach A, Doroszkiewicz W, Kozubek A. In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains. Int J Pharm. 2006;315(1-2): 59-66.
7. Sachetelli S, Khalil H, Chen T, Beaulac C, Sénéchal S, Lagacé J. Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells. Biochim Biophys Acta. 2000; 1463(2):254-266.
8. Rukholm G, Mugabe C, Azghani AO, Omri A. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill study. Int J Antimicrob Agents. 2006;27(3):247-252.
9. Drulis-Kawa Z, Dorotkiewicz-Jach A, Gubernator J, Gula G, Bocer T, Doroszkiewicz W. The interaction between Pseudomonas aeruginosa cells and cationic PC:Chol:DOTAP liposomal vesicles versus outer-membrane structure and envelope properties of bacterial cell. Int J Pharm. 2009;367(1-2):211-219.
10. Alipour M, Halwani M, Omri A, Suntres ZE. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Int J Pharm. 2008;355(1-2):293-298.
11. Hope MJ, Bally MB, Webb G, Cullis PR. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta. 1985;812(1):55-65.
12. Struck DK, Hoekstra D, Pagano RE. Use of resonance energy transfer to monitor membrane fusion. Biochemistry. 1981;20(14):4093-4099.
13. Huerta L, López-Balderas N, Larralde C, Lamoyi E. Discriminating in vitro cell fusion from cell aggregation by flow cytometry combined with fluorescence resonance energy transfer. J Virol Methods. 2006; 138(1-2):17-23.
14. Furuta RA, Nishikawa M, Fujisawa J. Real-time analysis of human immunodeficiency virus type 1 Env-mediated membrane fusion by fluorescence resonance energy transfer. Microbes Infect. 2006;8(2): 520-532.
15. Good L. Antisense inhibition of bacterial gene expression and cell growth. Methods Mol Biol. 2002;208:237-248.
16. Berger N, Sachse A, Bender J, Schubert R, Brandl M. Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics. Int J Pharm. 2001; 223(1-2):55-68.
17. Hope MJ, Bally MB, Mayer LD, Janoff AS, Cullis PR. Generation of multilamellar and unilamellar phospholipid vesicles. Chem Phys Lipids. 1986;40:89-107.
18. Kinnunen PK. On the molecular-level mechanisms of peripheral protein-membrane interactions induced by lipids forming inverted non-lamellar phases. Chem Phys Lipids. 1996;81(2):151-166.
19. van den Brink-van der Laan E, Killian JA, de Kruijff B. Nonbilayer lipids affect peripheral and integral membrane proteins via changes in the lateral pressure profile. Biochim Biophys Acta. 2004;1666(1-2): 275-288.
20. Shi G, Guo W, Stephenson SM, Lee RJ. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Control Release. 2002;80(1-3):309-319.
21. Ducat E, Deprez J, Gillet A, et al. Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles. Int J Pharm. 2011;420(2):319-332.
22. Bertrand N, Fleischer JG, Wasan KM, Leroux JC. Pharmacokinetics and biodistribution of N-isopropylacrylamide copolymers for the design of pH-sensitive liposomes. Biomaterials. 2009;30(13):2598-2605.
23. Yuba E, Harada A, Sakanishi Y, Kono K. Carboxylated hyperbranched poly(glycidol)s for preparation of pH-sensitive liposomes. J Control Release. 2011;149(1):72-80.
24. Sánchez M, Aranda FJ, Teruel JA, Ortiz A. New pH-sensitive liposomes containing phosphatidylethanolamine and a bacterial dirhamnolipid. Chem Phys Lipids. 2011;164(1):16-23.
25. Peschka-Süss R, Skalko-Basnet N. The association of plain and ligand-bearing neutral and pH-sensitive liposomes with various cells. J Liposome Res. 2000;10(1):43-59.
26. Huth US, Schubert R, Peschka-Süss R. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. J Control Release. 2006;110(3):490-504.
27. Lagacé J, Dubreuil M, Montplaisir S. Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa. J Microencapsul. 1991;8(1):53-61.
28. Torres Ieda Maria Sapateiro, Bento EB, et al. Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosastrains. Bra J Microbiol. 2012;43(3):1517-8382.
29. Semple SC, Chonn A, Cullis PR. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry. 1996; 35(8):2521-2525.
30. Dos Santos N, Cox KA, McKenzie CA, et al. pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol. Biochim Biophys Acta. 2004;1661(1): 47-60.
31. Shimanouchi T, Ishii H, Yoshimoto N, Umakoshi H, Kuboi R. Calcein permeation across phosphatidylcholine bilayer membrane: effects of membrane fluidity, liposome size, and immobilization. Colloids Surf B Biointerfaces. 2009;73(1):156-160.
32. Gregoriadis G, Davis C. Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. Biochem Biophys Res Commun. 1979;89(4):1287-1293.
33. Shinitzky M, Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim Biophys Acta. 1978; 515(4):367-394.
34. Mykytczuk NC, Trevors JT, Leduc LG, Ferroni GD. Fluorescence polarization in studies of bacterial cytoplasmic membrane fluidity under environmental stress. Prog Biophys Mol Biol. 2007;95(1-3):60-82.
35. Maruoka N, Murata T, Omata N, et al. Effects of chlorpromazine on plasma membrane permeability and fluidity in the rat brain: a dynamic positron autoradiography and fluorescence polarization study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(1):178-186.
36. Cullis PR, Verkleij AJ. Modulation of membrane structure by Ca2+ and dibucaine as detected by 31P NMR. Biochim Biophys Acta. 1979;552(3): 546-551.
37. Quinn PJ. A lipid matrix model of membrane raft structure. Prog Lipid Res. 2010;49(4):390-406.
38. Nayar R, Schmid SL, Hope MJ, Cullis PR. Structural preferences of phosphatidylinositol and phosphatidylinositol-phosphatidylethanolamine model membranes. Influence of Ca2+ and Mg2+. Biochim Biophys Acta. 1982;688(1):169-176.
39. Tilcock CP, Cullis PR, Gruner SM. Calcium-induced phase separation phenomena in multicomponent unsaturated lipid mixtures. Biochemistry. 1988;27(5):1415-1420.
40. Wilschut J, Scholma J, Eastman SJ, Hope MJ, Cullis PR. Ca(2+)-induced fusion of phospholipid vesicles containing free fatty acids: modulation by transmembrane pH gradients. Biochemistry. 1992;31(10): 2629-2636.